HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis

[1]  B. Liu,et al.  PO-282 Cancer-associated fibroblast-derived lumican promotes gastric cancer progression via the integrin beta1-FAK signalling pathway , 2018, ESMO Open.

[2]  L. Qin,et al.  FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells. , 2018, Cancer letters.

[3]  Bingya Liu,et al.  Cancer‐associated fibroblast‐derived Lumican promotes gastric cancer progression via the integrin β1‐FAK signaling pathway , 2017, International journal of cancer.

[4]  F. Alawi,et al.  Mesenchymal Stromal Cell‐Derived Interleukin‐6 Promotes Epithelial–Mesenchymal Transition and Acquisition of Epithelial Stem‐Like Cell Properties in Ameloblastoma Epithelial Cells , 2017, Stem cells.

[5]  Shouhao Zhou,et al.  IL6‐mediated inflammatory loop reprograms normal to epithelial‐mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta–deficient β2‐spectrin+/− mice , 2017, Hepatology.

[6]  E. Li,et al.  Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression , 2017, Nature Communications.

[7]  L. Trusolino.  Oncogenic MET as an Effective Therapeutic Target in Non-Small Cell Lung Cancer Resistant to EGFR Inhibitors: The Rise of the Phoenix. , 2016, Cancer discovery.

[8]  Keunchil Park,et al.  A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  R. Kalluri.  The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[10]  N. Tonks,et al.  HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer , 2016, Genes & development.

[11]  P. Gascard,et al.  Carcinoma-associated fibroblasts: orchestrating the composition of malignancy , 2016, Genes & development.

[12]  S. Dan,et al.  M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers. , 2016, Cancer research.

[13]  Genichiro Ishii,et al.  Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. , 2016, Advanced drug delivery reviews.

[14]  Chien-Liang Liu,et al.  Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors , 2016, Nature Medicine.

[15]  C. Isacke,et al.  Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness , 2016, Nature Communications.

[16]  R. Verhaak,et al.  Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. , 2015, Cancer research.

[17]  P. Maroni,et al.  HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells , 2015, Molecular Cancer.

[18]  B. Tang,et al.  Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis. , 2015, Cancer letters.

[19]  Ying Yu,et al.  Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment , 2015, Cell Research.

[20]  C. Sung,et al.  Twist1 is a key regulator of cancer-associated fibroblasts. , 2015, Cancer research.

[21]  長﨑 高也.  Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis : anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction , 2014 .

[22]  Shuwei Wang,et al.  The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review). , 2014, International journal of oncology.

[23]  M. Yashiro,et al.  Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts , 2014, Oncogene.

[24]  Mikinori Sato,et al.  Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction , 2013, British Journal of Cancer.

[25]  Yan Zhou,et al.  Effective Inhibition of c-MET-mediated Signaling, Growth, and Migration of Ovarian Cancer Cells is Influenced by the Ovarian Tissue Microenvironment , 2013, Oncogene.

[26]  T. Nakagawa,et al.  Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer , 2013, Cancer science.

[27]  Y. Qu,et al.  Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer. , 2013, Cancer letters.

[28]  Z. Duan,et al.  Interleukin-6 signaling pathway in targeted therapy for cancer. , 2012, Cancer treatment reviews.

[29]  Y. Toiyama,et al.  Co‐expression of hepatocyte growth factor and c‐Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c‐Met signaling in gastric cancer , 2012, International journal of cancer.

[30]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[31]  Jeffrey W. Clark,et al.  MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Laura H. Tang,et al.  MET Expression and Amplification in Patients with Localized Gastric Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[33]  Thinzar M. Lwin,et al.  Twist1-induced invadopodia formation promotes tumor metastasis. , 2011, Cancer cell.

[34]  P. Cirri,et al.  Cancer associated fibroblasts: the dark side of the coin. , 2011, American journal of cancer research.

[35]  A. Klein-Szanto,et al.  Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion , 2010, Proceedings of the National Academy of Sciences.

[36]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[37]  Hugh M. Davis,et al.  Pharmacokinetic and Pharmacodynamic Modeling of an Anti–Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma , 2010, Clinical Cancer Research.

[38]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[39]  Bonnie F. Sloane,et al.  Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. , 2009, Cancer research.

[40]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[41]  John Quackenbush,et al.  Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast Cancer , 2009, Clinical Cancer Research.

[42]  E. Tian,et al.  c-Met signaling promotes IL-6-induced myeloma cell proliferation , 2009, European journal of haematology.

[43]  Sushovan Guha,et al.  CXCL8/IL‐8 and CXCL12/SDF‐1α co‐operatively promote invasiveness and angiogenesis in pancreatic cancer , 2009 .

[44]  Timothy C Wang,et al.  Inflammation and cancer: IL-6 and STAT3 complete the link. , 2009, Cancer cell.

[45]  Sheng-Chieh Hsu,et al.  Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. , 2007, Cancer research.

[46]  M. Vitiello,et al.  STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6. , 2006, Cytokine.

[47]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[48]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[49]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[50]  Samuel M. Wilson.  The rise of phoenix. , 2001 .

[51]  A. Davies,et al.  Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. , 1997, Genes & development.

[52]  K. Matsumoto,et al.  Roles of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats. , 1997, Gastroenterology.

[53]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.